Texas Diabetes & Endocrinology, P.A. Report issue

Academic/Hospital Phase 2 Phase 3

Organization Overview

First Clinical Trial
2013
NCT01819272
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Texas Diabetes and Endocrinology, P.A. - Round Rock | Texas Diabetes & Endocrinology | Texas Diabetes & Endocrinology, P.A. | Texas Diabetes & Endocrinology, P.A. - Austin